"nasopharyngeal cancer" trang 3 - tải miễn phí từ tailieuXANH
The long-term survival of patients with IIIIVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: A propensity score-matched analysis

The long-term survival of patients with IIIIVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: A propensity score-matched analysis
12    42    0
Expression and clinical significance of PDL1 and BRAF expression in nasopharyngeal carcinoma

Expression and clinical significance of PDL1 and BRAF expression in nasopharyngeal carcinoma
8    80    0
Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
17    58    2
Prognostic value of neutrophil-tolymphocyte ratio in advanced nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

Prognostic value of neutrophil-tolymphocyte ratio in advanced nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area
8    61    0
Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigenspecific IgA seropositive population

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigenspecific IgA seropositive population
7    66    0
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
9    59    0
Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy

Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy
9    57    0
P53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma

P53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
8    62    0
Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma
13    54    0
The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma

The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma
8    84    0
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: A case–control study

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: A case–control study
11    117    0
Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas

Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas
11    86    0
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients

Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients
9    118    0
Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance
8    109    0
JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression

JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression
13    107    0
Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
10    99    0
Quantitation of DNA methylation in Epstein-Barr virus–associated nasopharyngeal carcinoma by bisulfite amplicon sequencing

Quantitation of DNA methylation in Epstein-Barr virus–associated nasopharyngeal carcinoma by bisulfite amplicon sequencing
9    105    0
Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A big-data, intelligence platform-based analysis

Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A big-data, intelligence platform-based analysis
9    67    0
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy
7    52    0
Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients

Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients
8    56    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.